Patients with a rare and often fatal brain disease caused by JC polyomavirus (JCV) infection fail to produce antibodies that eradicate the virus, creating “blind spots” that allow JCV to escape immune detection, according to two new studies. The findings suggest that a vaccine or antibody therapy may be able to close these blind spots, paving a path to preventing and treating this devastating disease.
↧